Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms and renal cancer risk.

Lipids in health and disease - 4 Nov 2015

Liu ZhiHong, Xiao YingMing, Tang LiangYou, Jiang Liang, Wang YuJie, Zhang RuoChen, Wei Qiang, Lu YiPing

Abstract excerpt

BACKGROUND: Apolipoprotein A1 (ApoA1) is the major apoprotein constituent of high-density lipoprotein that can play important roles in tumor invasion and metastasis. The objective of the present study was to evaluate the association of two genetic variants (-75 G/A and +83 C/T) of APOA1 with predisposition to renal cancer. METHODS: A total of 432 subjects, including 216 pathologically-proven renal cancer cases...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-I
Share to Carcinoma, Renal Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Gene Frequency

Share to Genetic Association Studies

Share to Kidney Neoplasms

Share to Lymphatic Metastasis

Share to Polymorphism, Restriction Fragment Length

Source

Open in PubMed Open full text

Identifiers

PMID: 26537097
DOI: 10.1186/s12944-015-0132-0
PMCID: PMC4634729

Genes

APOA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms and renal cancer risk.PMID 26537097Read ↗

Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.Semantic proximity Read ↗

Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms: susceptibility and prognostic implications in breast cancer.Semantic proximity Read ↗

Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study.Semantic proximity Read ↗

Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease.Semantic proximity Read ↗

The Apolipoprotein L1 Gene and Cardiovascular Disease.Semantic proximity Read ↗

Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studies.Semantic proximity Read ↗

Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis.Semantic proximity Read ↗

Polymorphisms of genes involved in lipid metabolism and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.Semantic proximity Read ↗

Genetic polymorphisms in APE1 are associated with renal cell carcinoma risk in a Chinese population.Semantic proximity Read ↗

Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas.Semantic proximity Read ↗

Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signalingSemantic proximity Read ↗

Genetic variation in IGF1 predicts renal cell carcinoma susceptibility and prognosis in Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.